KA/EN
Register
Medicines reference
Search
Search
Product

Hexacanivac

Favourites

Canine distemper virus + Canine parvovirus + Canine adenovirus + Leptospira icterohaemorrhagiae + Leptospira canicola · Kursk Biofactory / BIOK

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Enter weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
Suspension · Dog up to 5 kg Dog up to 5 kg 1.2 ml (2.2 ml)
Reconstitute immediately before use. Vaccinate clinically healthy dogs only. Do not use below 60 days or in the second half of pregnancy.
 · two doses 2-3 weeks apart from 60 days of age		 two doses 2-3 weeks apart from 60 days of age Georgia Yes, veterinary
In force until 20 Feb 2030
Veterinary (National Food Agency)
In the register: ჰექსაკანივაკი
№ 000796
Verified on: 21 Oct 2026
Suspension · Dog over 5 kg Dog over 5 kg 2.2 ml (2.2 ml)
Reconstitute immediately before use. Vaccinate clinically healthy dogs only. Do not use below 60 days or in the second half of pregnancy.
 · two doses 2-3 weeks apart from 60 days of age		 two doses 2-3 weeks apart from 60 days of age Georgia Yes, veterinary
In force until 20 Feb 2030
Veterinary (National Food Agency)
In the register: ჰექსაკანივაკი
№ 000796
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Hexacanivac, Suspension

combined vaccine, 5+5 doses for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.9/10
Weak evidence support
vetman assessment

Hexacanivac

combined vaccine, 5+5 doses for dogs
Assessed clinical scopeDog · Full dog label from 60 days: live distemper with inactivated parvovirus, adenovirus type 2 and two-serogroup leptospirosis (Icterohaemorrhagiae, Canicola) immunisation · SC,IM
Care settingPreventive veterinary vaccination of a healthy dog with examination and cold-chain control
vetman score 5.9/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000796 · Verified on 21 Oct 2026

A weak option: live distemper is useful, but inactivated parvovirus and adenovirus, two-serogroup leptospirosis and low regulatory transparency put it below EU-authorised modified-live vaccines.

Regulatory and scientific credibility5.0/10

The exact product is registered in Georgia (000796, valid to 2030) with a current manufacturer document, but it has no EU, UK or US authorisation documented in the reviewed evidence and no public dossier or independent product evidence.

Clinical efficacy5.5/10

Live distemper is well supported, but the parvovirus and adenovirus components are inactivated, which guidelines consider less effective against maternal antibody than modified-live vaccines, and leptospirosis cover is two serogroups.

Safety and tolerability7.0/10

The label restricts use to healthy dogs over 60 days and outside the second half of pregnancy; independent safety data are not available.

Clinical practicality6.5/10

Two doses 2-3 weeks apart after reconstitution are routine, but the multi-dose pack and inactivated components may need extra puppy doses.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Vaccinate only clinically healthy dogs; do not use under 60 days of age or in the second half of pregnancy.
  • Parvovirus and adenovirus components are inactivated; finish the puppy series at 16 weeks or later and prefer a modified-live parvovirus vaccine in high-risk settings.
  • It contains no rabies or parainfluenza antigen, and leptospirosis cover is limited to Icterohaemorrhagiae and Canicola.
  • Observe for allergic or local reactions after injection.
  • Reconstitute immediately before use and keep the cold chain at 2-8 C.
Assessment sources
  1. Hexacanivac instruction
  2. Georgia NFA register 20262026
  3. WSAVA vaccination 20242024
  4. ACVIM leptospirosis consensus 20232023
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus3.5 log10 TCID50/dose Canine parvovirus3 log10 HAU/dose Canine adenovirus3 log10 HAU/dose Leptospira icterohaemorrhagiae1.5 x10^8 cells/dose Leptospira canicola1.5 x10^8 cells/dose
Formulation Type
Suspension
Administration route
subcutaneous, intramuscular
Manufacturer
Kursk Biofactory / BIOK · Russia
Manufacturer (register)
Federal State Enterprise Kursk Biofabrika - Firm BIOK, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1311, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 20 Feb 2030
Veterinary (National Food Agency)
In the register: ჰექსაკანივაკი
№ 000796
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1.2 ml (2.2 ml)
Reconstitute immediately before use. Vaccinate clinically healthy dogs only. Do not use below 60 days or in the second half of pregnancy.
 Dog up to 5 kg subcutaneous,intramuscular two doses 2-3 weeks apart from 60 days of age
Hexacanivac instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hexacanivac - current registered instruction
Official manufacturer veterinary instruction
2.2 ml (2.2 ml)
Reconstitute immediately before use. Vaccinate clinically healthy dogs only. Do not use below 60 days or in the second half of pregnancy.
 Dog over 5 kg subcutaneous,intramuscular two doses 2-3 weeks apart from 60 days of age
Hexacanivac instruction
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Hexacanivac - current registered instruction
Official manufacturer veterinary instruction

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Canine adenovirus: No dose supported by a publicly verifiable source yet

Leptospira icterohaemorrhagiae: No dose supported by a publicly verifiable source yet

Leptospira canicola: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗